EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Behavioral Procrastination, Visceral Adiposity, and Insulin Resistance Phenotypes

Manuel Sarmiento-Cruz, Pedro Juan Tárraga López, Mónica Silu Piña Dabreu, Lluis Rodas Cañellas, Ángel Arturo López-González, José Ignacio Ramírez-Manent

Endocrines · 2026-10-08 · 7 (4) · 60

DOI: 10.3390/endocrines7040060 ↗
AbstractBibliografische Angaben

Abstract

Background. Behavioral procrastination has traditionally been considered a self-regulatory and psychological phenomenon; however, growing evidence suggests that chronic procrastination may also contribute to adverse physical health outcomes through persistent stress exposure, unhealthy lifestyle behaviors, and impaired long-term behavioral regulation. Nevertheless, its relationship with insulin resistance and visceral adiposity phenotypes remains poorly understood. Objective. To evaluate the association between behavioral procrastination and multiple validated surrogate indices of insulin resistance and visceral adiposity in a large occupational cohort of Spanish workers. Methods. A cross-sectional study was conducted among 92,184 Spanish workers aged 18–69 years who underwent standardized occupational health examinations between January 2021 and December 2024. Behavioral procrastination was assessed using a nine-item Spanish adaptation of the Pure Procrastination Scale (PPS-9) that has not been formally validated in the Spanish population; participants were classified into four operational, non-clinical categories. These categories were based on an unvalidated 9-item Spanish adaptation and operational, non-clinical cutoffs and should therefore not be interpreted as validated clinical levels of procrastination. Differences in the prevalence of adverse metabolic phenotypes across operational PPS-9 categories were assessed using Pearson’s chi-square test. Multivariable linear regression models with heteroscedasticity-consistent (HC3) robust standard errors were used to evaluate adjusted associations between operational PPS-9 categories and continuous insulin resistance and visceral adiposity phenotypes, with the very low/absent PPS-9 category as the reference group. Sex-stratified and sensitivity analyses were also performed. Results. The unadjusted prevalence of adverse metabolic phenotypes differed significantly across operational PPS-9 categories (all Pearson’s chi-square p < 0.001). In fully adjusted models, compared with participants in the very low/absent procrastination category, those in the very high/chronic category showed higher METS-IR (adjusted difference 19.478; 95% CI 19.193–19.763), LAP (47.504; 95% CI 45.518–49.490), VAI (4.174; 95% CI 3.813–4.534), METS-VF (1.310; 95% CI 1.290–1.330), and TyG index (0.230; 95% CI 0.203–0.257), together with lower SPISE (−3.725; 95% CI −3.775 to −3.674). Sex-stratified analyses showed adverse associations in both men and women, although their magnitude varied by metabolic phenotype. Sensitivity analyses excluding participants with diabetes mellitus yielded consistent findings. Sequential adjustment substantially attenuated some associations, particularly for the TyG index (70.6%) and VAI (50.7%), indicating that demographic and lifestyle factors accounted for a substantial proportion of the observed between-category differences, although residual associations remained after adjustment. Conclusions. Higher operational PPS-9 categories were associated with adverse insulin resistance and visceral adiposity phenotypes; however, substantial attenuation after demographic and lifestyle adjustment indicates that an important proportion of the observed differences is accounted for by covariate structure. Because the exposure was derived from an unvalidated 9-item Spanish adaptation of the PPS using operational, non-clinical cutoffs, these categories should not be interpreted as established clinical levels of procrastination. Given this measurement limitation, the cross-sectional design, and the marked age differences across categories, the findings should be interpreted cautiously and should not be considered evidence of an independent or causal metabolic effect of procrastination.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →